Cyclo-oxygenase-inhibitors increase morphine effects on mesolimbic dopamine neurons

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.387, Iss.1, 2000-11, pp. : 1-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB 1 receptors

By Gessa G. Melis M. Muntoni A. Diana M.

European Journal of Pharmacology, Vol. 341, Iss. 1, 1998-01 ,pp. : 39-44

Elsevier

Access to resources Recommend Favorite

Cyclo-Oxygenase-2 Inhibitors and the Kidney: A Case for Caution

By Noroian G. Clive D.

Drug Safety, Vol. 25, Iss. 3, 2002-01 ,pp. : 165-172

Adis International

Access to resources Recommend Favorite

Is there a Future for Cyclo-Oxygenase Inhibitors in Alzheimer's Disease?

By Ho Lap Qin Weiping Stetka Breton S. Pasinetti Giulio M.

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 85-98

Adis International

Access to resources Recommend Favorite

Balancing Gastroprotection and Cardioprotection with Selective Cyclo-Oxygenase-2 Inhibitors: Clinical Implications

By Meagher E.A.

Drug Safety, Vol. 26, Iss. 13, 2003-01 ,pp. : 913-924

Adis International

Access to resources Recommend Favorite

Cyclo-Oxygenase-2 Inhibitors: Rationale and Therapeutic Potential for Alzheimers Disease

By McGeer P.L.

Drugs & Aging, Vol. 17, Iss. 1, 2000-07 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite